{"id":140346,"title":"Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:14:14.654000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/pfizer-biontech-10-mcg-children-5-11-years-age/summary.html?wbdisable=true","snippet":"Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19] - Canada.ca Skip to main content Skip to \"About government\" We have…","rawSnapshotUrl":"/api/snapshots/raw/140346","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141414/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-covid-19-vaccines/pfizer-biontech-10-mcg-children-5-11-years-age/summary.html?wbdisable=true#ha_snapshot=140346","mimeType":"text/html","statusCode":200}